Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

CLEMASTINE FUMARATE

CLEMASTINE FUMARATE

Standard Dose
2.68MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview CLEMASTINE FUMARATE is listed in Drugs@FDA under application 073459 (ANDA).

Marketing status: Discontinued Active ingredient CLEMASTINE FUMARATE Form and strength TABLET;ORAL - 2.68MG Sponsor OMNIVIUM PHARMS Submission history Latest submission status date: 2002-12-16 00:00:00.

Structured Monograph

Clinical summary

Approval overview CLEMASTINE FUMARATE is listed in Drugs@FDA under application 073459 (ANDA). Marketing status: Discontinued Active ingredient CLEMASTINE FUMARATE Form and strength TABLET;ORAL - 2.68MG Sponsor OMNIVIUM PHARMS Submission history Latest submission status date: 2002-12-16 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
CLEMASTINE FUMARATE (CLEMASTINE FUMARATE) | Drug Monograph | MedicHelpline